Stocks › BXLT
BXLT
BXLT·USD
—
No end-of-day price on record
BXLT
BXLT
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
BXLTS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of BXLT by members of U.S. Congress · 7 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Richard L. HannaHouse · R · NY |
BXLTBXLT · Stock |
Sale $100,001 - $250,000 |
Feb 1, 2017 | Jun 3, 2016 | Filing ↗ |
 Frank A. LoBiondoHouse · R · NJ |
BXLTBXLT · Stock |
Sale $1,001 - $15,000 |
Jul 20, 2016 | Jul 30, 2015 | Filing ↗ |
 James B. RenacciHouse · R · OH |
BXLTBXLT · Stock |
Sale $100,001 - $250,000 |
Jan 27, 2016 | Jan 12, 2016 | Filing ↗ |
 K. Michael ConawayHouse · R · TX |
BXLTBXLT · Stock |
Sale $1,001 - $15,000 |
Nov 4, 2015 | Oct 2, 2015 | Filing ↗ |
| K. Michael ConawayHouse · R · TX |
BXLTBXLT · Stock |
Sale $1,001 - $15,000 |
Nov 4, 2015 | Oct 26, 2015 | Filing ↗ |
| James B. RenacciHouse · R · OH |
BXLTBXLT · Stock |
Purchase $15,001 - $50,000 |
Oct 20, 2015 | Oct 14, 2015 | Filing ↗ |
| James B. RenacciHouse · R · OH |
BXLTBXLT · Stock |
Purchase $15,001 - $50,000 |
Oct 5, 2015 | Sep 28, 2015 | Filing ↗ |
Whale Activity
Institutional 13F positions
No 13F positions in BXLT among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by BXLT insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
149 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Goff BrianEVP and President, Hematology | Disposition to issuer | −70.0K | — | — | Jun 3, 2016 | Form 4 ↗ |
| Goff BrianEVP and President, Hematology | Grant / award | +2,881 | $0.00 | $0 | Jun 3, 2016 | Form 4 ↗ |
| HOMBACH ROBERT J.EVP. CFO and COO | Disposition to issuer | −209.1K | — | — | Jun 3, 2016 | Form 4 ↗ |
| HOMBACH ROBERT J.EVP. CFO and COO | Grant / award | +16.4K | $0.00 | $0 | Jun 3, 2016 | Form 4 ↗ |
| GLASSPOOL JOHNSee Remarks | Disposition to issuer | −41.1K | — | — | Jun 3, 2016 | Form 4 ↗ |
| GLASSPOOL JOHNSee Remarks | Grant / award | +1,461 | $0.00 | $0 | Jun 3, 2016 | Form 4 ↗ |
| LEONARDI JACOPOEVP and President, Immunology | Disposition to issuer | −1,095 | — | — | Jun 3, 2016 | Form 4 ↗ |
| LEONARDI JACOPOEVP and President, Immunology | Disposition to issuer | −56.4K | — | — | Jun 3, 2016 | Form 4 ↗ |
| LEONARDI JACOPOEVP and President, Immunology | Grant / award | +1,033 | $0.00 | $0 | Jun 3, 2016 | Form 4 ↗ |
| STROUCKEN ALBERT P LDirector | Disposition to issuer | −696 | — | — | Jun 3, 2016 | Form 4 ↗ |
| STROUCKEN ALBERT P LDirector | Disposition to issuer | −22.2K | — | — | Jun 3, 2016 | Form 4 ↗ |
| ROSA-BJORKESON DAGMAREVP and President, Biosimilars | Disposition to issuer | −71.3K | — | — | Jun 3, 2016 | Form 4 ↗ |
| Edwards Peter GSVP and General Counsel | Disposition to issuer | −216.3K | — | — | Jun 3, 2016 | Form 4 ↗ |
| FOSLER GAIL DDirector | Disposition to issuer | −39.4K | — | — | Jun 3, 2016 | Form 4 ↗ |
| ORLOFF JOHN JSee Remarks | Disposition to issuer | −96.4K | — | — | Jun 3, 2016 | Form 4 ↗ |
| FORSYTH JOHN DDirector | Disposition to issuer | −27.8K | — | — | Jun 3, 2016 | Form 4 ↗ |
| Meek David D.EVP and President, Oncology | Disposition to issuer | −51.6K | — | — | Jun 3, 2016 | Form 4 ↗ |
| HANTSON LUDWIGPresident and CEO · Director | Disposition to issuer | −435.1K | — | — | Jun 3, 2016 | Form 4 ↗ |
| HANTSON LUDWIGPresident and CEO · Director | Grant / award | +16.4K | $0.00 | $0 | Jun 3, 2016 | Form 4 ↗ |
| HOCKMEYER WAYNE TDirector | Disposition to issuer | −19.0K | — | — | Jun 3, 2016 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding BXLT · SEC Form N-PORT
Funds report their holdings by CUSIP, and BXLT could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming BXLT as client
No lobbying filings found naming BXLT as the client.
Government Contracts
Federal awards to BXLT · USAspending
No federal contract awards found for BXLT.
U.S. Patents
Recent USPTO applications naming BXLT
No USPTO patent applications found for BXLT.
Annual Financials
From BXLT's 10-K filings · XBRL
No annual XBRL figures on record for BXLT. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No price history on record for BXLT.
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About BXLT
From SEC EDGAR company records
No company profile on record.